快速访问
文章信息
参考文献
[1]A T M, MARCO M, MARIANNA A, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure [J]. European heart journal, 2021, 42(36): 3599-3726.
[2]中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 中国心力衰竭基层诊疗与管理指南(实践版·2024) [J].中华全科医师杂志, 2024, 23(7): 683-693.
[3]何金龙. 慢性心力衰竭治疗策略研究进展 [J]. 中国医学创新, 2022, 19(33): 171-176.
[4]TAN Z Y, SU J, ZHANG J Y, et al. Copper homeostasis and cuproptosis in mitochondria [J]. Life Sciences, 2023, 33(4): 122223.
[5]LI Q W, LI J Z, LI C Q, et al. Metabolomics analysis reveals the effect of copper on autophagy in myocardia of pigs [J]. Ecotoxicology and Environmental Safety, 2021, 21(3): 112040.
[6]CHAN W Y, GARNICA A D, RENNERT O M. Cell culture studies of Menkes kinky hair disease [J]. Clinica Chimica Acta, 1978, 88(3): 495-507.
[7]CHEN X, CAI Q, LIANG R, et al. Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies [J]. Cell death & disease, 2023, 14(2): 105.
[8]TAVILOTI P, CAMBRE S, PETROVA B, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins [J]. Science (New York, N.Y.), 2022, 375(6586): 1254-1261.
[9]WANG N, ZHAO M J, HUANG K K, et al. Protein Folding Stability Changes Across the Proteome Reveal Targets of Cu Toxicity in E. coli [J]. ACS chemical biology, 2020, 16(1).
[10]GE E J, BUSH A I, CASINI A, et al. Connecting copper and cancer: from transition metal signalling to metalloplasia [J]. Nature Reviews Cancer, 2022, 22(2): 102-113.
[11]CHEN L, MA J, WANG F. Copper homeostasis and cuproptosis in health and disease [J]. Signal Transduction and Targeted Therapy, 2022, 7(1): 378-378.
[12]PARSANATHAN R. Copper's dual role: unravelling the link between copper homeostasis, cuproptosis, and cardiovascular diseases [J]. Hypertension research : official journal of the Japanese Society of Hypertension, 2024, 47(5): 1440-1442.
[13]FANG X, JI Y, LI S, et al. Paeoniflorin attenuates cuproptosis and ameliorates left ventricular remodeling after AMI in hypobaric hypoxia environments [J]. Journal of natural medicines, 2024, 78(3): 664-676.
[14]ELSAYED E I, WANG L, SCHNEIDER T J, et al. Regression of dietary copper restriction-induced cardiomyopathy by copper repletion in mice [J]. The Journal of nutrition, 2004, 134(4): 855-60.
[15]MALEK F, JIRESOVA E, DOHNALOVA A, et al. Serum copper as a marker of inflammation in prediction of short term outcome in high risk patients with chronic heart failure [J]. Int J Cardiol, 2006, 113(2): e51-e53.
[16]LIU R, YAO J, CHEN K, et al. Association between biomarkers of zinc and copper status and heart failure: a meta-analysis [J]. ESC heart failure, 2024, 11(5): 2546-2556.
[17]HUANG L, SHEN R H, HUANG L F, et al. Association between serum copper and heart failure: a meta-analysis [J]. Asia Pacific Journal of Clinical Nutrition, 2019, 28(4): 761-769.
[18]KANONENBERG K, VOUTILAINEN A, KOPONEN S, et al. Serum copper-to-zinc ratio is associated with heart failure and improves risk prediction in middle-aged and older Caucasian men: A prospective study [J]. Nutrition, metabolism, and cardiovascular diseases : NMCD, 2022, 32(8): 1924-1935.
[19]MARIJADRAGAN J, ALJOSAD M, SLOBODANM M, et al. Oxidative stress and its role in cancer [J]. Journal of Cancer Research and Therapeutics, 2019.
[20]YANG Y, QI F, YING L, et al. Exploring cuproptosis as a mechanism and potential intervention target in cardiovascular diseases [J]. Frontiers in Pharmacology, 2023, 141229297-1229297.
[21]SHIMADA K, REZNIK E, STOKES E M, et al. Copper-Binding Small Molecule Induces Oxidative Stress and Cell-Cycle Arrest in Glioblastoma-Patient-Derived Cells [J]. Cell Chemical Biology, 2018, 25(5): 585-594.e7.
[22]DI W, ZHENYU T, PENG Z, et al. The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease [J]. Biomedicine & Pharmacotherapy, 2023, 163: 114830.
[23]HAMMADAH M, FAN Y, WU Yet al. Prognostic Value of Elevated Serum Ceruloplasmin Levels in Patients With Heart Failure [J]. Journal of Cardiac Failure, 2014, 20(12): 946-952.
[24]HUAJING Y, YITAO X, YANG L. Cuproptosis, the novel therapeutic mechanism for heart failure: a narrative review [J]. Cardiovascular diagnosis and therapy, 2022, 12(5): 681-692.
[25]BARYLA A, GAWLIK V V, KONDRATENKO M S. Cd2+ -promoted mitochondrial permeability transition: a comparison with other heavy metals [J]. Acta biochimica Polonica, 2004, 51(2): 545-51.
[26]吴胜男, 王德国. 铜代谢及铜死亡在心肌病调控机制中的研究进展 [J]. 中华老年心脑血管病杂志, 2024, 26(10): 1235-1237.
[27]MEDEIROS M D, JIANG Y, KLAAHSEN D, et al. Mitochondrial and sarcoplasmic protein changes in hearts from copper-deficient rats: up-regulation of PGC-1α transcript and protein as a cause for mitochondrial biogenesis in copper deficiency [J]. The Journal of Nutritional Biochemistry, 2008, 20(10): 823-830.
[28]ABDEL RAHMAN R T, SIERRA R G, ZHENG M J, et al. Analysis of Copper-Induced Protein Precipitation across the E. coli Proteome [J]. Metallomics : integrated biometal science, 2022, 15(1).
[29]BRANCACCIO D, GALLO A, PICCIOLI M, et al. [4Fe-4S] cluster assembly in mitochondria and its impairment by copper [J]. Journal of the American Chemical Society, 2017, 139(2): 719-730.
[30]BOMER N, PAVEZ‐GIANI M G, GROTE BEVERBORG N, et al. Micronutrient deficiencies in heart failure: Mitochondrial dysfunction as a common pathophysiological mechanism? [J]. Journal of Internal Medicine, 2022, 291(6): 713-731.
[31]ZHANG S, LIU H, AMARSINGH G V, et al. Restoration of myocellular copper-trafficking proteins and mitochondrial copper enzymes repairs cardiac function in rats with diabetes-evoked heart failure [J]. Metallomics, 2020, 12(2): 259-272.
[32]KLAUDIA K, DAMIAN T, JANUSZ G, et al. Copper and Zinc Particles as Regulators of Cardiovascular System Function-A Review [J]. Nutrients, 2023, 15(13).
[33]BEGOÑA L, RAMÓN Q, ARANTXA G, et al. Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure [J]. Hypertension, 2009, 53(2): 236-242.
[34]DE ROMAÑA D L, OLIVARES M, UAUY R, et al. Risks and benefits of copper in light of new insights of copper homeostasis [J]. Journal of Trace Elements in Medicine and Biology, 2011, 25(1): 3-13.
[35]FERNS G A A, LAMB D J, TAYLOR A. The possible role of copper ions in atherogenesis: the Blue Janus [J]. Atherosclerosis, 1997, 133(2): 139-152.
[36]LUTSENKO S, BARNES N L, BARTEE M Y, et al. Function and regulation of human copper-transporting ATPases [J]. Physiological reviews, 2007, 87(3): 1011-46.
[37]NATALIA F, KATARZYNA L, M. J W. Proteolysis dysfunction in the process of aging and age-related diseases [J]. Frontiers in Aging, 2022, 3.
[38]SHAIK S, BURGER H, STREFFER C, et al. Ubiquitination and selective autophagy [J]. Cell death and differentiation, 2013, 20(1): 21-30.
[39]ZDENEK S, MARTIN M, KAAE K A, et al. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4 [J]. Nature, 2017, 552(7684): 194-199.
[40]Li H, Li Y, Yu Y, et al. GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF/Cu-induced cuproptosis in myelodysplastic syndromes [J]. Free Radical Biology and Medicine, 2024, 222: 130-148.
[41]COSTANZO S J G. Selective divalent copper chelation for the treatment of diabetes mellitus [J]. Current medicinal chemistry, 2012, 19(17): 2828-60.
[42]VARZANEH M B, RAHMANI H, JAHANIAN R, et al. The influence of oral copper-methionine on matrix metalloproteinase-2 gene expression and activation in right-sided heart failure induced by cold temperature: a broiler chicken perspective [J]. Journal of Trace Elements in Medicine and Biology, 2017, 39: 71-75.
[43]YANG L F, YANG P P, LI G H Y, et al. Copper homeostasis and cuproptosis in cardiovascular disease therapeutics [J]. Trends in pharmacological sciences, 2023, 44(9): 573-585.
[44]STREJCKOVA A, DVORAK M, KLEJDUS B, et al. The strong reaction of simple phenolic acids during oxidative stress caused by nickel, cadmium and copper in the microalga Scenedesmus quadricauda [J]. New BIOTECHNOLOGY, 2018, 4866-75.
[45]陈少影, 李晶晶, 兰卫.常用中药有效成分降脂作用研究进展 [J].中国实验方剂学杂志, 2023, 29(13): 241-253.DOI: 10.13422/j.cnki.syfjx.20230516.
[46]SOLEIMANI V, SAHEBKAR A, HOSSEINZADEH H. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: review. Phytother Res. 2018; 32: 985–95.
[47]BETÜL K, NEVİN Ş. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health [J]. Critical reviews in food science and nutrition, 2017, 57(13): 2889-2895.
[48]HEIDARI Z, KESHAVARZ D D. Turmeric and its bioactive constituents trigger cell signaling mechanisms that protect against diabetes and cardiovascular diseases [J]. Molecular and cellular biochemistry, 2021, 476(10): 1-30.
[49]徐磊, 莽靖, 徐忠信. 白藜芦醇抗动脉粥样硬化机制研究 [J]. 中风与神经疾病杂志, 2018, 35(06): 566-568.DOI: 10.19845/j.cnki.zfysjjbzz.2018.06.025.
[50]MAJEWSKI M, OGNIK K, JUŚKIEWICZ J. The interaction between resveratrol and two forms of copper as carbonate and nanoparticles on antioxidant mechanisms and vascular function in Wistar rats [J]. Pharmacological Reports, 2019, 71(5): 862-869.
版权与开放获取声明
作为一本开放获取的学术期刊，所有文章均遵循 Creative Commons Attribution 4.0 International License (CC BY 4.0) 协议发布，允许用户在署名原作者的前提下自由共享与再利用内容。所有文章均可免费供读者和机构阅读、下载、引用与传播，EWA Publishing 不会通过期刊的出版发行向读者或机构收取任何费用。